209 related articles for article (PubMed ID: 10549019)
1. [Human African trypanosomiasis: reviving the challenge for a re-emerging illness].
Bouteille B; Dumas M
Med Trop (Mars); 1999; 59(2 Suppl):20-4. PubMed ID: 10549019
[No Abstract] [Full Text] [Related]
2. Trypanosomiasis control, Democratic Republic of Congo, 1993-2003.
Lutumba P; Robays J; Miaka mia Bilenge C; Mesu VK; Molisho D; Declercq J; Van der Veken W; Meheus F; Jannin J; Boelaert M
Emerg Infect Dis; 2005 Sep; 11(9):1382-8. PubMed ID: 16229766
[TBL] [Abstract][Full Text] [Related]
3. Health care-seeking behaviour and diagnostic delays for Human African Trypanosomiasis in the Democratic Republic of the Congo.
Hasker E; Lumbala C; Mbo F; Mpanya A; Kande V; Lutumba P; Boelaert M
Trop Med Int Health; 2011 Jul; 16(7):869-74. PubMed ID: 21447063
[TBL] [Abstract][Full Text] [Related]
4. [Re-emergence of human African trypanosomiasis in Kinshasa, Democratic Republic of Congo (DRC)].
Tshimungu K; Okenge LN; Mukeba JN; de Mol P
Med Mal Infect; 2010 Aug; 40(8):462-7. PubMed ID: 20079989
[TBL] [Abstract][Full Text] [Related]
5. Gambiense sleeping sickness: re-emerging and soon untreatable?
Van Nieuwenhove S
Bull World Health Organ; 2000; 78(11):1283. PubMed ID: 11143187
[No Abstract] [Full Text] [Related]
6. [Epidemiological, clinical and sociodemographic characteristics of human African trypanosomiasis (HAT) in and around Kinshasa, Democratic Republic of Congo].
Tshimungu K; Okenge LN; Mukeba JN; Kande VB; De Mol P
Sante; 2009; 19(2):73-80. PubMed ID: 20031514
[TBL] [Abstract][Full Text] [Related]
7. High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo.
Robays J; Nyamowala G; Sese C; Betu Ku Mesu Kande V; Lutumba P; Van der Veken W; Boelaert M
Emerg Infect Dis; 2008 Jun; 14(6):966-7. PubMed ID: 18507916
[TBL] [Abstract][Full Text] [Related]
8. The situation of sleeping sickness in Angola: a calamity.
Stanghellini A; Josenando T
Trop Med Int Health; 2001 May; 6(5):330-4. PubMed ID: 11348527
[TBL] [Abstract][Full Text] [Related]
9. Sleeping sickness in Zaire.
van Hove D
Lancet; 1997 Feb; 349(9049):438. PubMed ID: 9033508
[No Abstract] [Full Text] [Related]
10. [Human African trypanosomiasis. The current epidemiologic situation, an alarming recrudescence of the disease].
Cattand PP
Bull Soc Pathol Exot; 1994; 87(5):307-10. PubMed ID: 7496190
[No Abstract] [Full Text] [Related]
11. Treatment outcomes for human African Trypanosomiasis in the Democratic Republic of the Congo: analysis of routine program data from the world's largest sleeping sickness control program.
Hasker E; Mpanya A; Makabuza J; Mbo F; Lumbala C; Kumpel J; Claeys Y; Kande V; Ravinetto R; Menten J; Lutumba P; Boelaert M
Trop Med Int Health; 2012 Sep; 17(9):1127-32. PubMed ID: 22809002
[TBL] [Abstract][Full Text] [Related]
12. Orchitis as an unusual manifestation of human African trypanosomiasis.
Ehrhardt S; Lippert U; Burchard GD; Sudeck H
J Infect; 2006 Jan; 52(1):e31-3. PubMed ID: 15936085
[TBL] [Abstract][Full Text] [Related]
13. [Has the focus of human African trypanosomiasis in Luba, Equatorial Guinea been eradicated?].
Simarro PP; Franco JR; Asumu PN
Med Trop (Mars); 2001; 61(4-5):441-4. PubMed ID: 11803839
[TBL] [Abstract][Full Text] [Related]
14. [Human African trypanosomiasis in the urban milieu: the example of Kinshasa, Democratic Republic if the Congo, in 1998 and 1999].
Bilengue CM; Meso VK; Louis FJ; Lucas P
Med Trop (Mars); 2001; 61(4-5):445-8. PubMed ID: 11803840
[TBL] [Abstract][Full Text] [Related]
15. Prospects for improving African trypanosomiasis chemotherapy.
Moore AC
J Infect Dis; 2005 Jun; 191(11):1793-5. PubMed ID: 15871110
[No Abstract] [Full Text] [Related]
16. Human African trypanosomiasis in the Democratic Republic of the Congo: a looming emergency?
Hasker E; Lutumba P; Chappuis F; Kande V; Potet J; De Weggheleire A; Kambo C; Depoortere E; Pécoul B; Boelaert M
PLoS Negl Trop Dis; 2012; 6(12):e1950. PubMed ID: 23272260
[No Abstract] [Full Text] [Related]
17. Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola.
Robays J; Raguenaud ME; Josenando T; Boelaert M
Trop Med Int Health; 2008 Feb; 13(2):265-71. PubMed ID: 18304274
[TBL] [Abstract][Full Text] [Related]
18. Human African trypanosomiasis.
Stich A; Abel PM; Krishna S
BMJ; 2002 Jul; 325(7357):203-6. PubMed ID: 12142311
[No Abstract] [Full Text] [Related]
19. Feasibility of a dried blood spot strategy for serological screening and surveillance to monitor elimination of Human African Trypanosomiasis in the Democratic Republic of the Congo.
Inocencio da Luz R; Phanzu DM; Kiabanzawoko ON; Miaka E; Verlé P; De Weggheleire A; Büscher P; Hasker E; Boelaert M
PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009407. PubMed ID: 34115754
[TBL] [Abstract][Full Text] [Related]
20. Drugs and drug resistance in African trypanosomiasis.
Delespaux V; de Koning HP
Drug Resist Updat; 2007; 10(1-2):30-50. PubMed ID: 17409013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
